Description
Founded in 1979, Industrifonden is a venture capital firm based in Stockholm, Sweden. The firm seeks to invest in the life science, health tech, medtech, deep technology, and transformative tech sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Viking Analytics | 26-Jan-2023 | Later Stage VC | 00.000 | Business/Productivity Software | Generating Revenue | 00000000 00000000 |
000000000 | 19-Dec-2022 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 0000000 00.0 |
00000000 | 15-Dec-2022 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000 00000000 00.0 |
00000 | 13-Dec-2022 | 0000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | 0000 00000 |
000000 | 23-Nov-2022 | 0000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | |
00000 (00000000000 | 12-Sep-2022 | 00000 00000 | 00.000 | Application Specific Semiconductors | Generating Revenue | 000 00000 |
000000000 | 07-Sep-2022 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
0000000 000000 | 01-Sep-2022 | 00000 00000 | Electrical Equipment | Generating Revenue | ||
Airsonett | 30-Jul-2022 | Later Stage VC | 00.000 | Other Devices and Supplies | Generating Revenue | 00000 00000 |
Oncopeptides | 14-Jul-2022 | PIPE | 000.00 | Pharmaceuticals | Generating Revenue/Not Profitable | 00000 00000000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Athera Biotechnologies | 01-Nov-2022 | Out of Business | |
0000000 | 01-Jul-2022 | 0000000000 | 00000 |
00000000000 | 01-Jun-2022 | 000000000 00000000 | 0000 |
000000000 | 12-May-2022 | 000000000000000000 | |
000000 00000 | 08-May-2022 | 000 00 00000000 | |
000000000 | 05-Nov-2021 | 0000000000 | 00.000 |
00000000 | 07-Jul-2021 | 000 | |
00000 | 20-May-2021 | 000 | 00.000 |
Micvac | 01-Apr-2021 | Secondary Transaction - Private | |
Barista c/o Coffee | 24-Mar-2021 | Out of Business |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Caroline Murray | Chief Financial Officer | Stockholm, Sweden | |||
Jonas Jendi | Chief Operating Officer | 0 | 0 | Stockholm, Sweden | |
Alex Basu Ph.D | Principal | 0 | 0 | Stockholm, Sweden | |
Caroline Wachtmeister | Principal | Stockholm, Sweden | |||
Fredrik von Porat | Business Controller | Stockholm, Sweden |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Fairpoint Capital | 5 | 0 | 0 |
![]() |
![]() |
Almi Invest | 0 | 0 |
![]() |
![]() |
|
Brightly Ventures | 0 | 0 |
![]() |
![]() |
|
Navigare Ventures | 0 | 0 |
![]() |
![]() |
|
Novo Holdings | 0 | 0 |
![]() |
![]() |